1 min read
CRO Summit
Veristat is excited to announce our participation in this year's CRO Summit, held on December 3-4, 2024, in Raleigh,...
Veristat to Co-Chair Session on Pharmacovigilance and Risk Management at DIA Canada Annual Meeting
October 18-19, 2022
Ottawa, Ontario, CANADA
Session 6, Track C: Monitoring Post-Market Compliance through GVP Inspections and Proactive Risk Management Projects
Oct 19, 2022 8:00 AM – Oct 19, 2022 9:15 AM
Session Chair(s)
Health Canada monitors compliance of health products on the market in various ways. One way is through the regular Good Pharmacovigilance Practices (GVP) inspection that verifies how the regulated parties meet the requirements under the Food and Drug Regulations. One additional way is through proactive compliance monitoring projects (CMPs). This session will focus on the ongoing initiatives in these programs and will give an overview of the current practices and perspectives of both industry and regulatory authorities.
Learning Objective- At the conclusion of this session, participants should be able to:
Meet Veristat at the meeting or learn more about our tailored PV Solutions to reduce risk.
If you would like to meet us at the DIA Canada, feel free to contact us to arrange a meeting through the form.
Website: DIA Annual Meeting Canada
1 min read
Oct 25, 2024 Veristat Events
Veristat is excited to announce our participation in this year's CRO Summit, held on December 3-4, 2024, in Raleigh,...
1 min read
Sep 13, 2024 Veristat Events
Meet Veristat in Boston at the Fierce Biotech Summit Conference | September 30 - October 1 in Boston, Massachusetts
We...